CVE-2008-3811

Description

Cisco IOS 12.2 and 12.4, when NAT Skinny Call Control Protocol (SCCP) Fragmentation Support is enabled, allows remote attackers to cause a denial of service (device reload) via segmented SCCP messages, aka Cisco Bug ID CSCsi17020, a different vulnerability than CVE-2008-3810.

Category

7.8
CVSS
Severity: High
CVSS 2.0 •
EPSS 1.92% Top 20%
Vendor Advisory cisco.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://secunia.com/advisories/31990 third party advisory
http://www.securitytracker.com/id?1020937 vdb entry
https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A5900 signature vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/45535 vdb entry
http://www.securityfocus.com/bid/31359 vdb entry
http://www.cisco.com/en/US/products/products_security_advisory09186a0080a0148e.shtml patch vendor advisory
http://www.vupen.com/english/advisories/2008/2670 vdb entry

Frequently Asked Questions

What is the severity of CVE-2008-3811?
CVE-2008-3811 has been scored as a high severity vulnerability.
How to fix CVE-2008-3811?
To fix CVE-2008-3811, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-3811 being actively exploited in the wild?
It is possible that CVE-2008-3811 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.